Open AccessAdvancing Inclusive Research: Establishing Collaborative Strategies to Improve Diversity in Clinical Trials
Author(s) -
Owen Garrick,
Ruben A. Mesa,
Andrea Ferris,
Edward S. Kim,
Edith P. Mitchell,
Otis W. Brawley,
John D. Carpten,
Keith D. Carter,
Joseph M Coney,
Robert A. Winn,
Stephanie Monroe,
Fabian Sandoval,
Edith A. Perez,
Mitzi Williams,
Evan Grove,
Quita Highsmith,
Nicole Richie,
Susan M. Begelman,
Asha S. Collins,
Jamie Freedman,
Melissa Gonzales,
Gerren Wilson
Publication year - 2022
Publication title -
ethnicity and disease
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 0.767
H-Index - 67
eISSN - 1945-0826
pISSN - 1049-510X
DOI - 10.18865/ed.32.1.61
Subject(s) - diversity (politics) , clinical trial , clinical research , health care , inclusion (mineral) , medicine , medical education , health equity , public relations , political science , psychology , social psychology , pathology , law
Well-characterized disparities in clinical research have disproportionately affected patients of color, particularly in underserved communities. To tackle these barriers, Genentech formed the External Council for Advancing Inclusive Research, a 14-person committee dedicated to developing strategies to increase clinical research participation. To help improve the recruitment and retention of patients of color, this article chronicles our efforts to tangibly address the clinical research barriers at the system, study, and patient levels over the last four years. These efforts are one of the initial steps to fully realize the promise of personalized health care and provide increased patient benefit at less cost to society. Instead of simply acknowledging the problem, here we illuminate the collaborative and multilevel strategies that have been effective in delivering meaningful progress for patients.Ethn Dis. 2022;32(1):61-68; doi:10.18865/ed.32.1.61